Merck & Co., Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRK.BA | AZN | PFE | GLAXO.NS | JNJ.DE | 0QYQ.IL | |
|---|---|---|---|---|---|---|
| Market cap | 12.43T | 293.14B | 175.50B | 423.55B | 597.98B | 215.56B |
| P/E (TTM) | 3.7 | 26.7 | 44.0 | 36.9 | 43.8 | 39.8 |
| Forward P/E | — | 16.7 | 10.6 | 31.6 | — | — |
| Price/book | 15.5 | 5.7 | 2.1 | 22.5 | 8.2 | 10.2 |
| Dividend yield | 2.07% | 1.69% | 5.59% | 2.25% | 1.99% | 3.81% |
| 1-year change | +89.42% | +12.81% | +23.90% | −3.14% | +50.29% | +38.91% |
| Today | +5.00% | +2.79% | +2.63% | −1.25% | +2.43% | +0.58% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All MRK.BA news ›Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.
Merck just posted its sixth straight earnings beat and its CEO is targeting $70 billion in mid-2030s revenue, yet the stock carries a looming patent cliff that could reshape everything. Whether the pipeline saves the story or the bears…
Lonza to Acquire Merck KGaA’s CDMO Business
The acquisition expands Lonza’s U.S. CDMO manufacturing footprint and adds end-to-end development and manufacturing capabilities in the U.S. Editor’s Take: Lonza is buying both specialized manufacturing expertise and a stronger position in…
Merck charts course out of CDMO business with Lonza sale
Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza, a top-three player in the category, for "a mid-triple-digit million-euro amount." The deal…
Merck KGaA to divest CDMO business to Lonza in mid-triple-digit million-euro deal
November 3, 2026 | Tuesday | News Lonza will acquire the business for a mid-triple-digit million-euro amount. The transaction is expected to close in mid-2027, subject to customary regulatory approvals and other closing conditions. Lonza…
Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers
Merck has invested more than €300 million in a new bioprocessing production center in Daejeon, South Korea. It is the largest life science investment Merck has made in the region to date. The 44,500-square-meter facility makes cell culture…
Lonza Buys 5 Sites From Germany's Merck To More Than Double US Footprint
Futures and options on butter and skimmed milk powder now trading. By Bhanvi Satija and Marleen Kaesebier Nov 3 (Reuters) - Contract drug manufacturer Lonza said on Tuesday it would buy five US manufacturing sites from Merck KGaA, more…
Reuters Health News Summary
Teva Pharmaceuticals said on Monday it was discontinuing its mid-stage neurodegenerative disorder study due to a low probability of the study meeting its main goal if continued. The company was testing its experimental oral drug,…
Merck Sells Its U.S. Contract Manufacturing Business to Switzerland
Merck is selling parts of its business to Switzerland. The Darmstadt-based DAX-listed company is striking a deal worth hundreds of millions with the Swiss firm Lonza. This move will help Merck raise its profile. The deal involves sites…
More from 1 other outlet
Massachusetts Biopharmaceutical Company Files for Chapter 11 Bankruptcy Amid Merger Plans
Karyopharm Therapeutics Inc., a Massachusetts-based developer of cancer treatments, has filed for Chapter 11 bankruptcy protection. The filing comes as the company plans to merge with another pharmaceutical company, Ayrmid Ltd., as part of…
Merck exits U.S. CDMO operations in sale to Lonza
Lonza buys five U.S. CDMO sites from Merck KGaA, expanding bioconjugates and viral vector capabilities. Merck KGaA (MKGAF) has agreed to sell five U.S. contract development and manufacturing (CDMO) sites to Swiss drug manufacturer Lonza…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com85
- marketbeat.com33
- themarketsdaily.com23
- seekingalpha.com20
- defenseworld.net18
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.